# Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

> **NCT05659368** · PHASE2 · UNKNOWN · sponsor: **Ospedale San Raffaele** · enrollment: 10 (estimated)

## Conditions studied

- Wolfram Syndrome

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT05659368
- **Lead sponsor:** Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2024-10
- **Final completion:** 2024-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05659368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05659368, "Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05659368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*